Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-03-19

Clinical Trial Update: Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir [Phase 3]

View source ↗

Summary

This is a Phase 3 open and comparative trial evaluating tolerability and efficacy of Taro Elixir for acne vulgaris and furuncles, sponsored by Laboratorios Goul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Taro Elixir

Snippet

Sponsor: Laboratorios Goulart S.A. | Conditions: Acne Vulgaris II or III Degree, Boils | Phase 3 | Status: UNKNOWN